EA200000140A1 - Способ лечения диабета тиазолидиндионом, средством, усиливающим секрецию инсулина, и ингибитором альфа-глюкозидазы - Google Patents

Способ лечения диабета тиазолидиндионом, средством, усиливающим секрецию инсулина, и ингибитором альфа-глюкозидазы

Info

Publication number
EA200000140A1
EA200000140A1 EA200000140A EA200000140A EA200000140A1 EA 200000140 A1 EA200000140 A1 EA 200000140A1 EA 200000140 A EA200000140 A EA 200000140A EA 200000140 A EA200000140 A EA 200000140A EA 200000140 A1 EA200000140 A1 EA 200000140A1
Authority
EA
Eurasian Patent Office
Prior art keywords
thiazolidindione
alpha
treating diabetes
insulin secretion
glucosidase inhibitor
Prior art date
Application number
EA200000140A
Other languages
English (en)
Russian (ru)
Inventor
Робин Эдвин Бакингэм
Стефен Элистэр Смит
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000140A1 publication Critical patent/EA200000140A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
EA200000140A 1997-07-18 1998-07-16 Способ лечения диабета тиазолидиндионом, средством, усиливающим секрецию инсулина, и ингибитором альфа-глюкозидазы EA200000140A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002112 WO1999003478A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Publications (1)

Publication Number Publication Date
EA200000140A1 true EA200000140A1 (ru) 2000-06-26

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000140A EA200000140A1 (ru) 1997-07-18 1998-07-16 Способ лечения диабета тиазолидиндионом, средством, усиливающим секрецию инсулина, и ингибитором альфа-глюкозидазы

Country Status (27)

Country Link
EP (1) EP1001784A1 (xx)
JP (1) JP2001510160A (xx)
KR (1) KR20010021952A (xx)
CN (1) CN1263467A (xx)
AP (1) AP2000001735A0 (xx)
AR (2) AR016350A1 (xx)
AU (1) AU8449098A (xx)
BG (1) BG104062A (xx)
BR (1) BR9810292A (xx)
CA (1) CA2297133A1 (xx)
CO (1) CO4940489A1 (xx)
DZ (1) DZ2563A1 (xx)
EA (1) EA200000140A1 (xx)
GB (1) GB9715298D0 (xx)
HU (1) HUP0003626A3 (xx)
ID (1) ID23804A (xx)
IL (1) IL133907A0 (xx)
MA (1) MA24608A1 (xx)
NO (1) NO20000230D0 (xx)
OA (1) OA11312A (xx)
PE (1) PE99499A1 (xx)
PL (1) PL338140A1 (xx)
SK (1) SK612000A3 (xx)
TR (1) TR200000133T2 (xx)
UY (1) UY25101A1 (xx)
WO (1) WO1999003478A1 (xx)
ZA (1) ZA986364B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
ATE372782T1 (de) 1999-06-21 2007-09-15 Lilly Co Eli Synergitische verwendung von thiazolidinedionen und glucagon-ähnlichem peptid-1 und dessen agonisten für die behandlung von nicht-insulin- abhängigen diabetes
DK1248604T4 (da) * 2000-01-21 2012-05-21 Novartis Ag Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
WO2001062295A1 (fr) * 2000-02-24 2001-08-30 Takeda Chemical Industries, Ltd. Medicaments contenant des ingredients actifs combines
CA2434169C (en) 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Spaced drug delivery system
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
WO2005041962A1 (en) 2003-10-31 2005-05-12 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2101866T3 (es) * 1991-08-26 1997-07-16 Upjohn Co Producto alimentario liquido que contiene acido 3-guanidinopropionico.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
BG104062A (en) 2000-11-30
AR019724A2 (es) 2002-03-13
HUP0003626A3 (en) 2001-12-28
EP1001784A1 (en) 2000-05-24
PE99499A1 (es) 1999-12-18
AU8449098A (en) 1999-02-10
GB9715298D0 (en) 1997-09-24
IL133907A0 (en) 2001-04-30
CA2297133A1 (en) 1999-01-28
NO20000230L (no) 2000-01-17
BR9810292A (pt) 2000-09-19
AR016350A1 (es) 2001-07-04
WO1999003478A1 (en) 1999-01-28
ID23804A (id) 2000-05-11
CO4940489A1 (es) 2000-07-24
JP2001510160A (ja) 2001-07-31
OA11312A (en) 2003-10-24
NO20000230D0 (no) 2000-01-17
ZA986364B (en) 2000-01-17
AP2000001735A0 (en) 2000-01-16
MA24608A1 (fr) 1999-04-01
UY25101A1 (es) 2000-12-29
CN1263467A (zh) 2000-08-16
DZ2563A1 (fr) 2003-02-15
PL338140A1 (en) 2000-09-25
KR20010021952A (ko) 2001-03-15
HUP0003626A2 (hu) 2001-05-28
TR200000133T2 (tr) 2000-09-21
SK612000A3 (en) 2000-07-11

Similar Documents

Publication Publication Date Title
HUP9700368A2 (hu) II-típusú diabetes mellitus kezelése amilin agonistákkal
EA199900725A1 (ru) Синергетические комбинации сульфонилмочевины и глитазона при лечении диабета
EA199800316A1 (ru) СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
EA199800667A1 (ru) Новые фенантридины
EA199800626A1 (ru) Применение агониста ppar-гамма для лечения синдрома х
AR012010A1 (es) Metodo para el procesamiento de una solucion acuosa de proteina c activada
EA200200105A1 (ru) СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ;
EA200300036A1 (ru) Комбинации ингибиторов дипептидилпептидазы iv и других антидиабетических агентов для лечения сахарного диабета
EA199700087A1 (ru) Способ ингибирования катепсина к
DE69009778T2 (de) Verwendung von selektiven gaba-b-agonisten als antitussiva.
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
FI945251A (fi) Menetelmä häiriöiden havaitsemiseksi dieselmoottorien käynnissä
EA200000140A1 (ru) Способ лечения диабета тиазолидиндионом, средством, усиливающим секрецию инсулина, и ингибитором альфа-глюкозидазы
EA200000139A1 (ru) Лечение диабета тиазолидиндионом, средством, стимулирующим секрецию инсулина, и дигуанидом
FR2759120B1 (fr) Pompe cryogenique, et blindage pour pompe cryogenique
FI951511A (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
EA200000040A1 (ru) Способ лечения диабета тиазолидиндионом и ингибитором альфа-глюкозидазы
EA199800816A1 (ru) Способы лечения и профилактики интерстициального цистита
EA200000039A1 (ru) Лечение диабета тиазолидиндионом и сульфонилмочевиной
EA200100501A1 (ru) Схема обезболивания
DE69805002T2 (de) Kv2.1 antagonisten
DE60028750D1 (de) Verwendung von tagatose zur verbesserung wichtiger blutfaktoren
EA199800822A1 (ru) Способ лечения избыточной агрессии
EA199800028A1 (ru) Винилсульфоксиды и способы их синтеза